Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anwesha Kar

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cells|July 26, 2020
CD38: T Cell Immuno-Metabolic ModulatorAnwesha Kar, Shikhar Mehrotra, Shilpak Chatterjee
Molecular Biology of the Cell|March 25, 2026
Interplay between membrane protrusive activities and their adhesion strength regulates cell migrationIndranil Ghosh, Ditipriya Mallick, Ankita Sen, et al.
ACR Open Rheumatology|October 13, 2025
IL-17<sup>+</sup>/IL-10<sup>+</sup> Ratio in TCRαβ<sup>+</sup> CD4<sup>-</sup> CD8<sup>-</sup> T Cells As a Marker of Disease Activity in Lupus-Prone Mice and Patients With Systemic Lupus ErythematosusRui Imai, Yi Li, Hao Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 7, 2024
CD38-RyR2 axis-mediated signaling impedes CD8<sup>+</sup> T cell response to anti-PD1 therapy in cancerAnwesha Kar, Puspendu Ghosh, Anupam Gautam, et al.
Cancer Research|June 1, 2022
Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8+ T CellsSnehanshu Chowdhury, Anwesha Kar, Debaleena Bhowmik, et al.
Science Advances|March 21, 2025
CD38-mediated metabolic reprogramming promotes the stability and suppressive function of regulatory T cells in tumorIshita Sarkar, Debashree Basak, Puspendu Ghosh, et al.
EMBO Reports|March 20, 2026
S1P-S1PR1 signaling impairs CD8<sup>+</sup> T cell metabolism and effector function in tumorsDebashree Basak, Puspendu Ghosh, Anupam Gautam, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cells|July 26, 2020
CD38: T Cell Immuno-Metabolic ModulatorAnwesha Kar, Shikhar Mehrotra, Shilpak Chatterjee
Molecular Biology of the Cell|March 25, 2026
Interplay between membrane protrusive activities and their adhesion strength regulates cell migrationIndranil Ghosh, Ditipriya Mallick, Ankita Sen, et al.
ACR Open Rheumatology|October 13, 2025
IL-17<sup>+</sup>/IL-10<sup>+</sup> Ratio in TCRαβ<sup>+</sup> CD4<sup>-</sup> CD8<sup>-</sup> T Cells As a Marker of Disease Activity in Lupus-Prone Mice and Patients With Systemic Lupus ErythematosusRui Imai, Yi Li, Hao Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 7, 2024
CD38-RyR2 axis-mediated signaling impedes CD8<sup>+</sup> T cell response to anti-PD1 therapy in cancerAnwesha Kar, Puspendu Ghosh, Anupam Gautam, et al.
Cancer Research|June 1, 2022
Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8+ T CellsSnehanshu Chowdhury, Anwesha Kar, Debaleena Bhowmik, et al.
Science Advances|March 21, 2025
CD38-mediated metabolic reprogramming promotes the stability and suppressive function of regulatory T cells in tumorIshita Sarkar, Debashree Basak, Puspendu Ghosh, et al.
EMBO Reports|March 20, 2026
S1P-S1PR1 signaling impairs CD8<sup>+</sup> T cell metabolism and effector function in tumorsDebashree Basak, Puspendu Ghosh, Anupam Gautam, et al.
Pageof 1